Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MeCIS: Fluticasone in Asthma
NCT00705341Phase 4Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Jan 2009
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone propionate nasal spray in asthma (4 arms), sponsored by Johns Hopkins Bloomberg School of Public Health. Primary endpoint: Methacholine Challenge Test Result for Phase 2 at 4 weeks. Started Jan 2009; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00705341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00705341.